Opportunities for Patient Education in Oncology

Video

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the expanding role of educational patient support programs in oncology.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the expanding role of educational patient support programs in oncology.

Related Videos
MP Studio - stock.adobe.com
luckybusiness - stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Home Diabetes Treatment - Image credit: Dglimages | stock.adobe.com
Image credit: Azee/peopleimages.com | stock.adobe.com
Image credit: Elena | stock.adobe.com
Cropped view of senior man playing with puzzles on table- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Breast cancer with lymphatics, medically 3D illustration | Image Credit: Axel Kock - stock.adobe.com
Woman with pink ribbon on color background. Breast cancer awareness concept | Image Credit: Pixel-Shot - stock.adobe.com
Related Content
Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL

Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL

December 11th 2023
Article
Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies

November 28th 2023
Podcast
Assessing Clinical Trial Efficacy vs Real-World Effectiveness in the Treatment of Multiple Myeloma

Assessing Clinical Trial Efficacy vs Real-World Effectiveness in the Treatment of Multiple Myeloma

December 10th 2023
Article
Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation

Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation

October 24th 2023
Podcast
Women with cancer receiving treatment

No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens

December 8th 2023
Article
FDA Approves Casgevy, Lyfgenia for the Treatment of Sickle Cell Disease

FDA Approves Casgevy, Lyfgenia for the Treatment of Sickle Cell Disease

December 8th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.